Clinical Investigation for Everolimus Drug Eluting Stent

Clinical trial NCT06769217 · COMPLETED

Trial details

NCT number: NCT06769217
Sponsor: Frisch Medical Device Private Limited
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Arterial Disease (CAD)

Start date: 2023-01-01
Primary completion: 2024-11-08
Enrollment: 888

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.